Ad-hoc News

01.07.2013

Dr. Mathias P. Schlichting, member and chairman of the Supervisory Board of MOLOGEN AG, resigned from office today due to health reasons as previously announced. After co-ordination with the remaining members of the Supervisory Board the Executive...

03.06.2013

Dr. Mathias P. Schlichting, member and chairman of the Supervisory Board of MOLOGEN AG has informed the company today that he will resign from office due to health reasons prior to this year’s annual general meeting of the company.

The...

26.03.2013

MOLOGEN AG is pleased to announce the appointment of Dr. Alfredo Zurlo as member of the executive board and Chief Medical Officer. As of April 1st, 2013 Dr. Zurlo, a board-certified oncologist with strong expertise in the pharma industry, will shape...

       

Share Subscription Facility with US investor GCF

Further Information

Contact:
Claudia Nickolaus
Head of Investor Relations & Corporate Communications

T. +49 (0) 30 - 84 17 88 - 86
F. +49 (0) 30 - 84 17 88 - 50

investor@mologen.com